Advisor Resource Council Alkermes Plc. Transaction History
Advisor Resource Council
- $137 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$961 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$611 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$405 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$291 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$250 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.42B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...